Latest News

  • PARTNERSHIPS

    16 Dec 2025

    Why Moderna’s Nanexa Pact Matters More Than It Looks
  • INNOVATION

    12 Dec 2025

    How Advanced Manufacturing Is Reshaping US Pharma
  • PARTNERSHIPS

    9 Dec 2025

    Halozyme Bets Big on the Future of Biologics Delivery
  • RESEARCH

    21 Nov 2025

    Why Drug Delivery Is the New Power Move

Can One Small Shot Last a Year? MIT Thinks So

MIT campus sign in front of the university’s main entrance with people walking past

INNOVATION

19 Nov 2025

A preclinical MIT injection draws growing attention from drugmakers

Biologic Breakthrough or Bet? Axio and Likarda Join Forces

PARTNERSHIPS

14 Oct 2025

Biologic Breakthrough or Bet? Axio and Likarda Join Forces

New partnership weaves delivery into early biologic design, sparking cautious optimism for future impact

Wearables and Biologics Push Care Beyond the Clinic

INSIGHTS

13 Oct 2025

Wearables and Biologics Push Care Beyond the Clinic

US firms pioneer wearable and greener drug-delivery systems as biologics reshape patient care

A $900 Million Shot: Halozyme Targets Smoother Drug Delivery

RESEARCH

10 Oct 2025

A $900 Million Shot: Halozyme Targets Smoother Drug Delivery

Halozyme’s $900M Elektrofi deal aims to speed up and simplify injectable biologic treatments

Faster Shots for Cancer Care: Merck’s Keytruda Qlex Debuts

INNOVATION

8 Oct 2025

Faster Shots for Cancer Care: Merck’s Keytruda Qlex Debuts

Merck’s subcutaneous Keytruda Qlex offers faster cancer dosing, though IV remains the mainstay for most patients.

Evonik–Ethris Alliance Targets Next Leap in RNA Medicine

INVESTMENT

22 Sep 2025

Evonik–Ethris Alliance Targets Next Leap in RNA Medicine

Alliance aims to improve RNA stability and scaling, with potential to ease storage demands and broaden access

Nanoparticles targeting cells in Wyss Institute’s ENTER non-viral delivery innovation

INNOVATION

22 Jun 2025

Can These Nanoparticles Outsmart Your Cells?

Wyss Institute’s nanoparticle system improves precision and safety in non-viral gene and mRNA therapies

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.